{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:13:33Z","timestamp":1784765613312,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.leukres.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T18:12:23Z","timestamp":1427652743000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Martin D.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Leibundgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M.","family":"Baerlocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Seipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice U.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Ruefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.03.004_bib0155","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2015.03.004_bib0160","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2015.03.004_bib0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2141.2003.04140.x","article-title":"Outcome of autologous transplantation for mantle-cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries","volume":"120","author":"Vandenberghe","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0170","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","article-title":"Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma","volume":"325","author":"Gribben","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2015.03.004_bib0175","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO.1995.13.5.1073","article-title":"Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma","volume":"13","author":"Hardingham","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0180","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1200\/JCO.1996.14.9.2454","article-title":"Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry","volume":"14","author":"Williams","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/blood.V79.4.1074.bloodjournal7941074","article-title":"Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique","volume":"79","author":"Sharp","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V91.1.331","article-title":"Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources","volume":"91","author":"L\u00e9onard","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0195","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1705668","article-title":"Viral purging of haematological autografts: should we sneeze on the graft?","volume":"40","author":"Thirukkumaran","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.004_bib0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/106161299320488","article-title":"Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device","volume":"8","author":"Schumm","year":"1999","journal-title":"J Hematother"},{"key":"10.1016\/j.leukres.2015.03.004_bib0210","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2012.41.7071","volume":"30","author":"Pasquini","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2141.2004.05062.x","article-title":"CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients","volume":"126","author":"Ringhoffer","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0220","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbmt.2011.08.017","article-title":"Characteristics of CliniMACS\u00ae System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303","volume":"18","author":"Keever-Taylor","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.004_bib0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2141.2002.03561.x","article-title":"Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices","volume":"118","author":"Watts","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2141.2005.05827.x","article-title":"Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device","volume":"132","author":"van Heeckeren","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1703124","article-title":"Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation","volume":"28","author":"Demirkazik","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.004_bib0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V76.1.235.235","article-title":"T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications","volume":"76","author":"Anderson","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0250","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0301-472X(02)00828-7","article-title":"CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections","volume":"30","author":"Alt\u00e8s","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0255","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V91.7.2588","article-title":"Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors","volume":"91","author":"Bomberger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0260","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/bbmt.2001.v7.pm11787531","article-title":"Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma","volume":"7","author":"Vose","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.004_bib0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1634\/stemcells.2005-0613","article-title":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells","volume":"25","author":"Witzens-Harig","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.leukres.2015.03.004_bib0270","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","article-title":"Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation","volume":"94","author":"Holmberg","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0275","first-page":"1858","article-title":"Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma","volume":"93","author":"Vescio","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.03.004_bib0280","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00277-002-0528-6","article-title":"Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission","volume":"81","author":"De Rosa","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0285","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1701637","article-title":"Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?","volume":"7","author":"Jacquy","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2015.03.004_bib0290","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjh.12664","article-title":"Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma","volume":"164","author":"Yahng","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0295","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2141.2000.02244.x","article-title":"A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells","volume":"110","author":"Jacquy","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2015.03.004_bib0300","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/00313020701684417","article-title":"Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study","volume":"39","author":"Talaulikar","year":"2007","journal-title":"Pathology"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T08:07:02Z","timestamp":1598861222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0145212615000739"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.03.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}